Open Access Research article

Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand

Leonardo M Simonella12*, Hazel Lewis3, Megan Smith14, Harold Neal3, Collette Bromhead5 and Karen Canfell146

Author Affiliations

1 Cancer Epidemiology Research Unit, Cancer Council NSW 153 Dowling Street, Woolloomooloo, Australia

2 Present address: Saw Swee Hock School of Public Health, National University of Singapore, 6 Medical Drive, Block MD3, Level 3, Singapore 117597, Singapore

3 National Cervical Screening Programme, Ministry of Health, 133 Molesworth Street, Thorndon, Wellington, New Zealand

4 Lowy Cancer Research Centre, The University of NSW, Sydney, NSW 2052, Australia

5 Molecular Biology, Aotea Pathology, CMC Building 89 Courtenay Place, Wellington, New Zealand

6 School of Public Health, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia

For all author emails, please log on.

BMC Infectious Diseases 2013, 13:114  doi:10.1186/1471-2334-13-114

Published: 3 March 2013

Additional files

Additional file 1: Appendix Figure 1A:

Recruitment process for women who provided a sample during colposcopy. Figure 2A. Recruitment process for women approached to provide consent to test after a high grade cytology result used to notify NCSP-R. Table 1A. Oncogenic HPV prevalence by age in high grade cytology and in histologically-confirmed CIN 2/3. Table 2A. Oncogenic HPV prevalence by age in histologically-confirmed disease, by subcategory (CIN2, CIN3 and CIN2/3 combined). Table 3A. Type-specific prevalence of oncogenic HPV in histologically-confirmed CIN2+ by sample collection method.

Format: DOC Size: 273KB Download file

This file can be viewed with: Microsoft Word Viewer

Open Data